Literature DB >> 20193001

Monosodium urate crystals in inflammation and immunity.

Yan Shi1, Ashley D Mucsi, Gilbert Ng.   

Abstract

Uric acid crystals [monosodium urate (MSU)] have emerged as an important factor for both gouty arthritis and immune regulation. This simple crystalline structure appears to activate innate host defense mechanisms in multiple ways and triggers robust inflammation and immune activation. The recognition mechanisms of MSU following its phase change from soluble uric acid are diverse, involving both protein receptors and non-specific plasma membrane attachment. Upon contact with host cells, MSU induces a set of membrane events that trigger Syk and PI3K activation, phagocytosis, and cytokine production. Having entered the cell, MSU further triggers NALP3 inflammasome activation and induces the production of IL-1 beta, likely inducing a full spectrum of inflammation. This review describes the recognition mechanisms and activation pathways involved in MSU-mediated inflammation and adjuvanticity and hypothesizes that direct membrane binding by solid surfaces, such as MSU, may function as a generic mechanism in tissue responses to particulate and crystalline structures.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20193001     DOI: 10.1111/j.0105-2896.2009.00851.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  47 in total

1.  Caught red-handed: uric acid is an agent of inflammation.

Authors:  Yan Shi
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

2.  Mucosal production of uric acid by airway epithelial cells contributes to particulate matter-induced allergic sensitization.

Authors:  M J Gold; P R Hiebert; H Y Park; D Stefanowicz; A Le; M R Starkey; A Deane; A C Brown; G Liu; J C Horvat; Z A Ibrahim; M B Sukkar; P M Hansbro; C Carlsten; S VanEeden; D D Sin; K M McNagny; D A Knight; J A Hirota
Journal:  Mucosal Immunol       Date:  2015-10-28       Impact factor: 7.313

3.  Phagocytosed Clofazimine Biocrystals Can Modulate Innate Immune Signaling by Inhibiting TNFα and Boosting IL-1RA Secretion.

Authors:  Gi S Yoon; Sudha Sud; Rahul K Keswani; Jason Baik; Theodore J Standiford; Kathleen A Stringer; Gus R Rosania
Journal:  Mol Pharm       Date:  2015-06-05       Impact factor: 4.939

4.  Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignancies.

Authors:  Sebastian P Haen; Vicky Eyb; Nora Mirza; Aline Naumann; Andreas Peter; Markus W Löffler; Christoph Faul; Wichard Vogel; Wolfgang A Bethge; Hans-Georg Rammensee; Lothar Kanz; Martin Heni
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-16       Impact factor: 4.553

Review 5.  Inflammasomes and metabolic disorders: old genes in modern diseases.

Authors:  Gregory R Robbins; Haitao Wen; Jenny P-Y Ting
Journal:  Mol Cell       Date:  2014-04-24       Impact factor: 17.970

6.  Activation of human fibroblast-like synoviocytes by uric acid crystals in rheumatoid arthritis.

Authors:  Da P Chen; Chun K Wong; Lai S Tam; Edmund K Li; Christopher W K Lam
Journal:  Cell Mol Immunol       Date:  2011-09-26       Impact factor: 11.530

Review 7.  Uric acid and xanthine oxidoreductase in wound healing.

Authors:  Melissa L Fernandez; Zee Upton; Gary K Shooter
Journal:  Curr Rheumatol Rep       Date:  2014-02       Impact factor: 4.592

Review 8.  Update on biology: uric acid and the activation of immune and inflammatory cells.

Authors:  Fabio Martinon
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

9.  Biological Activities of Uric Acid in Infection Due to Enteropathogenic and Shiga-Toxigenic Escherichia coli.

Authors:  John K Crane; Jacqueline E Broome; Agnieszka Lis
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

10.  Radiation exposure induces inflammasome pathway activation in immune cells.

Authors:  Veit M Stoecklein; Akinori Osuka; Shizu Ishikawa; Madeline R Lederer; Lorenz Wanke-Jellinek; James A Lederer
Journal:  J Immunol       Date:  2014-12-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.